Pacific Biosciences (PACB) And GenDx Initiate Co-Marketing Activities For Full-Length HLA Gene Sequencing Products
6/19/2014 8:39:54 AM
UTRECHT, The Netherlands and MENLO PARK, Calif., June 19, 2014 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc., (Nasdaq:PACB) provider of the PacBio® RS II DNA Sequencing System, and GenDx, a pioneer in the area of sequence-based typing and next-generation sequencing for HLA typing, today announced a co-marketing agreement to offer products for full-length HLA gene sequencing.
Help employers find you! Check out all the jobs and post your resume.
comments powered by